BACKGROUND: Little is known about nasopharyngeal carriage and the patterns of antibiotic resistance of pneumococci in Pacific nations. We set out to document pneumococcal nasopharyngeal carriage and associated risk factors, antimicrobial resistance and serotypes in healthy children in Fiji. METHODS: A cross-sectional survey of healthy children aged 3-13 months was conducted. Nasopharyngeal (NP) swabs were collected from each child and processed according to standard methods. Antimicrobial resistance was determined by disk diffusion and confirmed by E-testing. Serotyping was performed by the Quellung reaction. RESULTS: Of 440 consecutive NP swabs taken, 195 were S. pneumoniae-positive (carriage rate 44.3%). Higher rates were found in the indigenous Fijian population. Penicillin non-susceptibility was found in 11.4% of isolates, with one isolate demonstrating high-level resistance. Cotrimoxazole resistance was common (20.3%) and no isolates were chloramphenicol-resistant. Multi-drug resistance was uncommon. The commonest serotypes were 6A (13.2%), 23F (8.3%), 19F (7.4%) and 6B (6.2%). Thirty per cent were included in the 7-valent pneumococcal conjugate vaccine (PCV), 54.3% if cross-reacting strains were included. Being indigenous Fijian or having symptoms of acute respiratory infection were independent risk factors for carriage. CONCLUSIONS: Pneumococcal NP carriage is common in Fijian children. Penicillin resistance has been documented for the first time in Fiji and, as a result, first-line treatment for meningitis has been altered. Being indigenous Fijian is a risk factor for disease, although the reasons for this are unclear. A low proportion of carriage serotypes are covered by the existing 7-valent PCV.
BACKGROUND: Little is known about nasopharyngeal carriage and the patterns of antibiotic resistance of pneumococci in Pacific nations. We set out to document pneumococcal nasopharyngeal carriage and associated risk factors, antimicrobial resistance and serotypes in healthy children in Fiji. METHODS: A cross-sectional survey of healthy children aged 3-13 months was conducted. Nasopharyngeal (NP) swabs were collected from each child and processed according to standard methods. Antimicrobial resistance was determined by disk diffusion and confirmed by E-testing. Serotyping was performed by the Quellung reaction. RESULTS: Of 440 consecutive NP swabs taken, 195 were S. pneumoniae-positive (carriage rate 44.3%). Higher rates were found in the indigenous Fijian population. Penicillin non-susceptibility was found in 11.4% of isolates, with one isolate demonstrating high-level resistance. Cotrimoxazole resistance was common (20.3%) and no isolates were chloramphenicol-resistant. Multi-drug resistance was uncommon. The commonest serotypes were 6A (13.2%), 23F (8.3%), 19F (7.4%) and 6B (6.2%). Thirty per cent were included in the 7-valent pneumococcal conjugate vaccine (PCV), 54.3% if cross-reacting strains were included. Being indigenous Fijian or having symptoms of acute respiratory infection were independent risk factors for carriage. CONCLUSIONS:Pneumococcal NP carriage is common in Fijian children. Penicillin resistance has been documented for the first time in Fiji and, as a result, first-line treatment for meningitis has been altered. Being indigenous Fijian is a risk factor for disease, although the reasons for this are unclear. A low proportion of carriage serotypes are covered by the existing 7-valent PCV.
Authors: Eileen M Dunne; Jayne Manning; Fiona M Russell; Roy M Robins-Browne; E Kim Mulholland; Catherine Satzke Journal: J Clin Microbiol Date: 2011-12-14 Impact factor: 5.948
Authors: Laura K Boelsen; Eileen M Dunne; Karen E Lamb; Kathryn Bright; Yin Bun Cheung; Lisi Tikoduadua; Fiona M Russell; E Kim Mulholland; Paul V Licciardi; Catherine Satzke Journal: Vaccine Date: 2015-07-29 Impact factor: 3.641
Authors: Miwako Kobayashi; Laura M Conklin; Godfrey Bigogo; Geofrey Jagero; Lee Hampton; Katherine E Fleming-Dutra; Muthoni Junghae; Maria da Gloria Carvalho; Fabiana Pimenta; Bernard Beall; Thomas Taylor; Kayla F Laserson; John Vulule; Chris Van Beneden; Lindsay Kim; Daniel R Feikin; Cynthia G Whitney; Robert F Breiman Journal: BMC Infect Dis Date: 2017-01-05 Impact factor: 3.090
Authors: Eileen M Dunne; Catherine Satzke; Felisita T Ratu; Eleanor F G Neal; Laura K Boelsen; Silivia Matanitobua; Casey L Pell; Monica L Nation; Belinda D Ortika; Rita Reyburn; Kylie Jenkins; Cattram Nguyen; Katherine Gould; Jason Hinds; Lisi Tikoduadua; Joseph Kado; Eric Rafai; Mike Kama; E Kim Mulholland; Fiona M Russell Journal: Lancet Glob Health Date: 2018-12 Impact factor: 26.763
Authors: S F La Vincente; C von Mollendorf; M Ulziibayar; C Satzke; L Dashtseren; K K Fox; E M Dunne; C D Nguyen; J de Campo; M de Campo; H Thomson; G Surenkhand; S Demberelsuren; S Bujinlkham; L A H Do; D Narangerel; T Cherian; T Mungun; E K Mulholland Journal: BMC Public Health Date: 2019-03-21 Impact factor: 3.295
Authors: Ifedayo M O Adetifa; Martin Antonio; Christy A N Okoromah; Chinelo Ebruke; Victor Inem; David Nsekpong; Abdoulie Bojang; Richard A Adegbola Journal: PLoS One Date: 2012-01-24 Impact factor: 3.240
Authors: Richard A Adegbola; Rodrigo DeAntonio; Philip C Hill; Anna Roca; Effua Usuf; Bernard Hoet; Brian M Greenwood Journal: PLoS One Date: 2014-08-01 Impact factor: 3.240
Authors: Eleanor F G Neal; Cattram D Nguyen; Felista T Ratu; Eileen M Dunne; Mike Kama; Belinda D Ortika; Laura K Boelsen; Joseph Kado; Lisi Tikoduadua; Rachel Devi; Evelyn Tuivaga; Rita C Reyburn; Catherine Satzke; Eric Rafai; E Kim Mulholland; Fiona M Russell Journal: PLoS One Date: 2020-04-01 Impact factor: 3.240
Authors: Eleanor F G Neal; Stefan Flasche; Cattram D Nguyen; F Tupou Ratu; Eileen M Dunne; Lanieta Koyamaibole; Rita Reyburn; Eric Rafai; Mike Kama; Belinda D Ortika; Laura K Boelsen; Joseph Kado; Lisi Tikoduadua; Rachel Devi; Evelyn Tuivaga; Catherine Satzke; E Kim Mulholland; W John Edmunds; Fiona M Russell Journal: Vaccine Date: 2019-10-23 Impact factor: 3.641